SUPN Supernus: Future Profit

Corporate company logo of Supernus Pharmaceuticals, Inc. (SUPN)

The cash return forecast for Supernus Pharmaceuticals (SUPN) demonstrates the company's success in developing extended-release drug delivery systems for the CNS. A stable staff of neurobiologists ensures the advancement of these technologies, while the 0.48 level represents the current metric value. However, investors should consider the threats associated with the expiration of patent protection for ADHD medications and pressure from generics.

Supernus Corp (SUPN): Forward Earnings from 07/04/2022 to 11/18/2026

Supernus Corp - analytical breakdowns and key metrics (SUPN)

General company analysis:supernus.com
Core merchandise of Supernus Pharma

This indicator measures the expected operational efficiency of the business, filtering out market noise and determining the real potential for future cash flow generation. An analysis of the forward net income metric for Supernus Pharmaceuticals (SUPN) reflects the monetization of their patents in the field of extended-release medications for ADHD treatment, allowing investors to assess the sustainability of the company's high margins.

Main competitors

BIIB (Biogen) - Projected Future Earnings|Net Profit Forecast NBIX (Neurocrine Biosciences, Inc.)|Projected Future Earnings RGC|Axsome Corp - Net Profit Forecast|Projected Future Earnings ACAD (ACADIA Corp)|XENE: Net Profit Forecast|Viking Therapeutics Inc - Projected Future Earnings|CPRX - Projected Future Earnings|Denali Therapeutics Inc (DNLI) - Expected Profit|Expected Net Profit Harmony Corp (HRMY)|Future Profit BHVN|Net Profit Forecast AMLX (Amylyx Pharmaceuticals, Inc.)|Future Profit TRVI (Trevi Therapeutics)|PRAX (Praxis Precision Medicines Inc) - Expected Net Income|Expected Profit Anavex Corp AVXL|CeriBell, Inc. - Expected Profit|PRTA: Future Profit|Company Profit Forecast Alector ALEC|Annexon Inc. (ANNX) - Expected Profit|Omeros Corp. - Expected Net Income|NGNE (Neurogene Therapeutics) - Projected Future Earnings|Future Profit AC Immune Corp (ACIU)|Expected Profit Voyager Therapeutics (VYGR)|NMRA (Neumora Therapeutics) - Expected Net Income|Expected Profit Scilex Holding Co. SCLX|Expected Net Income TVGN|ACOG - Expected Profit|Expected Net Income CGTX (Cognition Therapeutics, Inc.)|IKT: Projected Future Earnings|Expected Net Profit cassavasciences.com (SAVA)|ASRT (Assertio Holdings, Inc.) - Projected Future Earnings|Future Profit coyatherapeutics.com (COYA)|Future Profit VTGN (vistagen.com)|Company Profit Forecast Ovid Rx|Projected Future Earnings ABOS (acumenpharm.com)|CRVO: Net Profit Forecast|Alterity Therapeutics Ltd. - Projected Future Earnings|Expected Net Profit clene.com|pepgen.com (PEPG) - Expected Profit|Expected Net Profit Jupiter Neurosciences, Inc. (JUNS)|Expected Profit Relmada Therapeutics|Net Profit Forecast ANVS (Annovis Bio, Inc.)|Projected Future Earnings GRCE|Company Profit Forecast Firefly Neuroscience, Inc.|Expected Profit anewmeds.com KLTO|Company Profit Forecast NeuroSense Therapeutics (NRSN)|RVPH: Future Profit|MTVA - Projected Future Earnings|NRXS (neuraxis.com) - Future Profit|Expected Net Profit Helius Medical Technologies Inc. (HSDT)|Expected Profit Passage Bio Corp|Future Profit Neuphoria Therapeutics (NEUP)|Projected Future Earnings NERV|ATHA - Expected Net Profit|Projected Future Earnings ADXN (addextherapeutics.com)|Alzamend (ALZN) - Expected Net Profit|CYCN: Future Profit|Expected Net Profit Protagenic Therapeutics Inc.|pasitheaclinics.com (KTTA) - Expected Profit|Expected Net Profit Cortigent Medical (CRGT)|ATXI (Avenue Therapeutics Inc) - Projected Future Earnings|BCLI (Brainstorm Cell Therapeutics Inc.) - Future Net Profit|Projected Future Earnings CARA|CHRO - Expected Net Profit|Eliem Therapeutics - Future Profit|Intra-Cellular (ITCI) - Expected Net Profit|LBPH - Expected Profit|MRNS - Projected Future Earnings|NKGN: Projected Future Earnings|NeuroBo Pharma (NRBO) - Projected Future Earnings|Future Profit SAGE|Net Profit Forecast SNPX (Synaptogenix, Inc.)|Expected Profit Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Expected Net Income|Expected Profit Anew Medical WENA|Future Net Profit CERE (Cerevel)